Dermata Therapeutics Inc (NASDAQ: DRMA): Stock Forecast For 2025 Still Looks Weak With A -380.0% Decline
In today’s recent session, 3.5 million shares of the Dermata Therapeutics Inc (NASDAQ:DRMA) have been traded, and its beta is 0.68. Most recently the company’s